Halozyme Therapeutics (LTS:0J2O) Inventories, Raw Materials & Components : $29.1 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Halozyme Therapeutics Inventories, Raw Materials & Components?

Halozyme Therapeutics's inventories, raw materials & components for the quarter that ended in Mar. 2024 was $29.1 Mil.

Halozyme Therapeutics's quarterly raw materials declined from Sep. 2023 ($26.9 Mil) to Dec. 2023 ($23.6 Mil) but then increased from Dec. 2023 ($23.6 Mil) to Mar. 2024 ($29.1 Mil).

Halozyme Therapeutics's annual raw materials increased from Dec. 2021 ($10.7 Mil) to Dec. 2022 ($13.8 Mil) and increased from Dec. 2022 ($13.8 Mil) to Dec. 2023 ($23.6 Mil).

Halozyme Therapeutics Inventories, Raw Materials & Components Historical Data

The historical data trend for Halozyme Therapeutics's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Halozyme Therapeutics Inventories, Raw Materials & Components Chart

Halozyme Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Inventories, Raw Materials & Components

Get a 7-Day Free Trial

2.77

5.81

10.67

13.79

23.65

Halozyme Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Inventories, Raw Materials & Components	Get a 7-Day Free Trial															22.45	24.21	26.93	23.65	29.11

Halozyme Therapeutics Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

Halozyme Therapeutics (LTS:0J2O) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Halozyme Therapeutics Inc (LTS:0J2O) » Definitions » Inventories, Raw Materials & Components

Comparable Companies

Traded in Other Exchanges

HALO:USA RV7:Germany

Address

12390 El Camino Real, San Diego, CA, USA, 92130

Website

https://www.halozyme.com

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeutic areas with significant unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Halozyme Therapeutics (LTS:0J2O) Headlines

No Headlines